Founded with a mission to refine cellular medicine through biodata analytics, Greyledge Technologies specializes in autologous cell therapeutics, including Platelet Rich Plasma (PRP) and Bone Marrow Concentrate (BMC). The company develops advanced quality control systems to process biologic therapy products derived from a patient’s own blood or bone marrow tissue. This innovative approach allows for precise measurement and quantification of complex cell populations, enabling customized treatments tailored to individual patients and specific clinical applications.
Greyledge Technologies has garnered trust from leading medical professionals and institutions due to its pioneering methods in biodata analytics and product optimization. Notable achievements include significant advancements in the scientific understanding of cell-based therapies and their applications in treating orthopedic conditions. By combining detailed product analytics with patient-reported outcomes, Greyledge has made a substantial impact on the field of cellular medicine, setting new standards for quality and efficacy in biologic therapies.
Greyledge Technologies' most recent funding round was for $4.3M (USD) in April 2022.
As of Apr 4, 2022, Greyledge Technologies has disclosed funding of $6.8M (USD).
EndoCellutions
endocellutions.com

Platelet BioGenesis

GID BIO
gidbio.com

Circle Biologics

Trailhead Biosystems
trailbio.com

PRP Concepts
prpconcepts.com

Antria
antria.org

Celularity
celularity.com

Stemedica Cell Technologies
stemedica.com

Bone Biologics
bonebiologics.com

ZEO ScientifiX
zeoscientifix.com

Gift of Life Biologics
giftoflifebio.com

Allele Biotechnology
allelebiotech.com

Jointechlabs
jointechlabs.com
ReLive
relivebio.com

Kincell Bio
kincellbio.com

ElevateBio
elevate.bio

Silene Biotech
silenebiotech.com

RoosterBio
roosterbio.com

Cellective BioTherapy